|
Showing the most relevant articles for your search:AMEX:ANX | Date | Time | Source | Headline | Symbol | Company | | 05/21/2009 | 6:03AM | Edgar (US Regulatory) | Securities Registration Statement (simplified form) (S-3) | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/15/2009 | 9:00AM | Edgar (US Regulatory) | Quarterly Report (10-Q) | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/12/2009 | 6:20PM | PR Newswire (US) | ADVENTRX Pharmaceuticals Reports First Quarter 2009 Financial Results | AMEX:ANX | |
| 05/12/2009 | 10:04AM | Marketwired | MaybachFinancial.com Posts Free Analyst Report on ANX, CX, DCT and GLD | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/07/2009 | 4:36PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/07/2009 | 4:35PM | PR Newswire (US) | ADVENTRX Announces Results From ANX-514 Bioequivalence Study | AMEX:ANX | |
| 04/30/2009 | 9:00AM | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/01/2009 | 5:21PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/27/2009 | 9:01AM | Edgar (US Regulatory) | Annual Report (10-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/25/2009 | 9:02AM | PR Newswire (US) | ADVENTRX Grants Exclusive Rights to ANX-514 in South Korea | AMEX:ANX | |
| 03/25/2009 | 9:01AM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/25/2009 | 9:01AM | PR Newswire (US) | ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results | AMEX:ANX | |
| 03/20/2009 | 4:04PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/20/2009 | 4:01PM | PR Newswire (US) | ADVENTRX Announces Further Cost-Cutting Measures | AMEX:ANX | |
| 02/10/2009 | 9:00AM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/10/2009 | 9:00AM | PR Newswire (US) | ADVENTRX Provides Update on Strategic Transaction Process | AMEX:ANX | |
| 02/06/2009 | 3:59PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/05/2009 | 4:13PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/05/2009 | 6:00AM | PR Newswire (US) | ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study | AMEX:ANX | |
| 02/03/2009 | 3:01PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/03/2009 | 2:59PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/03/2009 | 2:56PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/03/2009 | 2:54PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/02/2009 | 4:24PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/08/2009 | 4:51PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/05/2009 | 4:17PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/05/2009 | 4:01PM | PR Newswire (US) | ADVENTRX Announces Further Cost-Cutting Measures | AMEX:ANX | |
| 01/02/2009 | 4:02PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 12/23/2008 | 4:08PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 12/15/2008 | 4:07PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
|
Showing the most relevant articles for your search:AMEX:ANX |
|